Pharmaceutical Drugs


Although pharmaceutical drugs on the whole greatly improve patient outcomes and quality of life when used as prescribed, they are not without their complications. RAND research on pharmaceuticals examines their safety and effectiveness, relevant health economics issues, prescription drug abuse, challenges related to access and adherence, and pharmaceutical regulatory policy.

  • Assorted colorful pills and capsules of medication, photo by Philip Dyer/iStock


    Alternative Financing Schemes May Be Needed to Pay for Expensive New Medications

    Mar 11, 2015

    In an era of $1,000-a-pill medications, a new approach may be needed to finance an emerging breed of highly expensive pharmaceuticals and vaccines. Health care could learn from other industries, where it is common for suppliers to encourage investment through approaches such as equipment leases or supplier-financed credit.

  • Blue and green pills and tablets, photo by ShutterWorx/iStock


    Biosimilar Medications Could Create Billions in Health Care Savings

    Nov 3, 2014

    Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such as cancer and rheumatoid arthritis could cut spending on biologics in the United States by $44 billion over the next decade.

Explore Pharmaceutical Drugs

Research conducted by